Thanks Xena….great posts from falconer as usual! With Rett.org funding and clear phase 2 approval....who did not expect some dose ranging element? This is all good news...and means we will get both Parkinson and Rett read-outs in 2019! And I expect an Alzheimer's interim report as well...2019 will be an important year in all 3 indications IMO!
Falconer comments from way back when, see linked post:
Why is his defense of a placebo-less trial appealing to you. AVXL had already announced in 12/17 that the Rett trial would be placebo controlled. Even before they announced it why would anyone think otherwise.
Market Data 
Markets 
AI
